- Home
- AXIL vs DYAI Comparison
AXIL vs DYAI Comparison
Compare AXIL & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXIL
- DYAI
- Stock Information
- Founded
- AXIL 2015
- DYAI 1979
- Country
- AXIL United States
- DYAI United States
- Employees
- AXIL N/A
- DYAI N/A
- Industry
- AXIL Package Goods/Cosmetics
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXIL Consumer Discretionary
- DYAI Health Care
- Exchange
- AXIL Nasdaq
- DYAI Nasdaq
- Market Cap
- AXIL 29.2M
- DYAI 31.3M
- IPO Year
- AXIL N/A
- DYAI 2004
- Fundamental
- Price
- AXIL $5.59
- DYAI $0.99
- Analyst Decision
- AXIL
- DYAI Strong Buy
- Analyst Count
- AXIL 0
- DYAI 1
- Target Price
- AXIL N/A
- DYAI $6.00
- AVG Volume (30 Days)
- AXIL 6.9K
- DYAI 36.6K
- Earning Date
- AXIL 04-08-2025
- DYAI 05-14-2025
- Dividend Yield
- AXIL N/A
- DYAI N/A
- EPS Growth
- AXIL 93.65
- DYAI N/A
- EPS
- AXIL 0.29
- DYAI N/A
- Revenue
- AXIL $27,007,463.00
- DYAI $3,554,344.00
- Revenue This Year
- AXIL N/A
- DYAI $22.56
- Revenue Next Year
- AXIL N/A
- DYAI $30.95
- P/E Ratio
- AXIL $20.99
- DYAI N/A
- Revenue Growth
- AXIL N/A
- DYAI 57.59
- 52 Week Low
- AXIL $3.54
- DYAI $0.93
- 52 Week High
- AXIL $11.49
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- AXIL 39.71
- DYAI 39.68
- Support Level
- AXIL $5.37
- DYAI $0.95
- Resistance Level
- AXIL $6.25
- DYAI $1.13
- Average True Range (ATR)
- AXIL 0.45
- DYAI 0.08
- MACD
- AXIL -0.07
- DYAI 0.00
- Stochastic Oscillator
- AXIL 15.94
- DYAI 30.00
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.